ArticleAmerican journal of translational research2024
Hysteroscopy improves surgical outcomes of hydatidiform moles while reducing postoperative residuals.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical efficacy of hysteroscopy in the treatment of molar pregnancy and postoperative residual tissue.
methodsThis retrospective study involved 68 patients who underwent treatment for molar pregnancy in Shanxi Children's Hospital Shanxi Maternal and Child Health Hospital from April 2020 to May 2022. Based on intervention methods, patients were divided into a conventional group (n=33) and a hysteroscopy group (n=35). The effects of different treatment methods on perioperative outcomes, prognosis, serum factor levels and complication rates were compared between the two groups.
resultsThe comparison of general data, including age, gestational times, the number of patients with a cleared uterus, and the time interval from the last menstruation to hysteroscopic surgery, showed no significant differences between the two groups (all P > 0.05). The operation duration and menstrual recovery time of the hysteroscopy group were significantly shorter than those of the conventional group, and the intraoperative blood loss was significantly less than that in the conventional group (all P < 0.05). After surgery, endometrial thickness in hysteroscopy group was significantly thinner than that in conventional group (P < 0.05), though there was no significant difference in uterine adhesion rates (P > 0.05). Before surgery, there was no significant difference in serum factor levels between the two groups (P > 0.05). After surgery, the levels of β-human chorionic gonadotropin (β-HCG), creatine kinase (CK), trend factor interleukin-10 (CXCL10), and placental growth factor (PlGF) in the hysteroscopic group were all lower than those in the conventional group (all P < 0.05), while pregnancy-associated plasma protein-A (PAPP-A) was higher. The cure rate in the hysteroscopy group was significantly higher, while the total incidence of complications was significantly lower than those in the conventional group (all P < 0.05).
conclusionHysteroscopic treatment for molar pregnancy effectively removes lesions, reduces the treatment load, and provides the potential to preserve fertility function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.